March 14, 2025 - 03:10

Battered by higher prescription drug costs and increased patient use of medical services, Highmark Health has reported significant financial losses in 2024. The organization revealed that its operating revenue took a substantial hit, primarily due to escalating expenses associated with pharmaceuticals and a surge in demand for healthcare services.
As more patients seek medical attention, the costs associated with providing care have risen sharply. This trend has placed additional strain on Highmark Health's financial resources, leading to an operating loss that has raised concerns among stakeholders. The increased utilization of healthcare services, coupled with the rising prices of prescription medications, has created a challenging environment for the organization.
Highmark Health's leadership is now tasked with navigating these turbulent waters, focusing on strategies to mitigate losses while continuing to provide essential services to its members. The organization is exploring various avenues to enhance operational efficiency and manage costs effectively in the face of these ongoing challenges.
March 31, 2026 - 08:40
SF Supervisor Jackie Fielder on leave due to mental health condition; her staff set to take overSan Francisco Supervisor Jackie Fielder is taking a temporary leave of absence from her official duties to address a mental health condition, her office confirmed this week. The announcement...
March 30, 2026 - 19:56
CVS Health puts creative and media in reviewCVS Health has launched a comprehensive review of its creative and media agency partnerships, a significant move that puts its substantial advertising account under scrutiny. This decision comes as...
March 30, 2026 - 15:51
New £1.5m research facility plan for New Cross HospitalA major £1.5 million investment is set to establish a new clinical research facility at New Cross Hospital, a move heralded by NHS leaders as a significant advancement for patient care, medical...
March 29, 2026 - 18:52
Makers of dietary supplements push the FDA to allow peptides and other new ingredientsThe dietary supplement industry is actively urging the U.S. Food and Drug Administration to modernize its regulatory approach to allow novel ingredients, including peptides and other compounds,...